| | Cancer | Pancreatic Cancer
Pancreatic Secretion: Hormonal, Neural, and Nutrient Regulation of Exocrine & Endocrine Output
The pancreas integrates hormonal, neural, and nutrient signals to deliver precisely calibrated exocrine (digestive enzymes, bicarbonate) and endocrine (insulin, glucagon, somatostatin, pancreatic polypeptide) secretions.
Exocrine Secretion Regulation
1. Cephalic Phase (20–25% of response)
- Stimuli: Sight, smell, taste, chewing (sham feeding).
- Pathway: Vagus (CN X) → ACh → M3 receptors on acinar (enzymes) and ductal (HCO₃⁻) cells.
- Modulation: GRP (gastrin-releasing peptide) from enteric neurons potentiates.
2. Gastric Phase (10–15%)
- Stimuli: Gastric distension, peptides/amino acids.
- Pathway: Vagovagal reflex + gastrin (G cells) → CCK₂ receptors on acinar cells.
3. Intestinal Phase (60–70%) — Major Phase
- Cholecystokinin (CCK): I cells (duodenum/jejunum) → fats (especially long-chain), proteins → CCK → CCK₁ receptors on acinar cells (enzymes) + vagal afferents → pancreatic secretion.
- Secretin: S cells (duodenum) → acidic chyme (pH <4.5) → secretin → secretin receptors on ductal cells → HCO₃⁻-rich fluid (neutralizes acid, optimal pH for enzymes).
- GIP (Glucose-dependent insulinotropic polypeptide): K cells → fats/glucose → potentiates insulin; minor exocrine effect.
4. Neural-Hormonal Integration
- CCK and secretin potentiate vagal effects (synergy).
- Somatostatin (D cells, δ cells) inhibits CCK, secretin, gastrin, and direct pancreatic secretion (paracrine/endocrine).
- Pancreatic polypeptide (PP cells) — feedback inhibition of exocrine secretion.
Endocrine Secretion (Islets of Langerhans)
Insulin (β-cells)
- Primary stimulus: Glucose >5 mM → glycolysis → ATP/ADP ↑ → K_ATP channel closure → depolarization → Ca²⁺ influx → exocytosis.
- Amplifiers: Incretins (GLP-1, GIP) → cAMP → potentiate glucose-stimulated insulin secretion (GSIS).
- Inhibitors: Somatostatin, α-adrenergic (norepinephrine), leptin.
Glucagon (α-cells)
- Stimuli: Low glucose, amino acids (arginine), catecholamines (β-adrenergic), exercise.
- Inhibited by: Insulin, somatostatin, GLP-1, hyperglycemia.
Somatostatin (δ-cells)
- Paracrine brake on insulin, glucagon, exocrine secretion.
- Stimulated by: Nutrients, glucagon, VIP, CCK.
Clinical Correlations
- Pancreatitis: Premature trypsinogen activation; alcohol, gallstones, hypertriglyceridemia, ERCP.
- Cystic fibrosis: CFTR defect → viscous secretions → ductal obstruction → exocrine insufficiency.
- Diabetes: T1D (β-cell loss); T2D (insulin resistance + β-cell dysfunction + incretin defect).
- Neuroendocrine tumors: Insulinoma, gastrinoma, VIPoma, glucagonoma — hormone hypersecretion syndromes.
- Secretin stimulation test: Gold standard for exocrine function (CF, chronic pancreatitis).
The pancreas operates as a unified organ: exocrine and endocrine components communicate via islet-acinar portal system, ensuring digestion and metabolism remain synchronized.
Pancreatic Cancer - Related Articles
- Pancreatic Stents: Indications, Types, Procedure, and Outcomes
- Understanding Pancreatic Cancer: Causes, Risk Factors & Prevention
- Pancreas vs. Kidneys: Two Organs, Two Distinct Roles
- Pancytopenia: Causes, Workup, and Management Principles
- Pancreas Healing: Why Pressure Points Can't Replace Medical Care
- Pancreatic Damage Assessment: Clinical Evaluation, Labs, Imaging, and Biopsy
- Heterogeneous Pancreas: Causes, Functional Impact, and Clinical Management
